Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer

F. Grossi, C. Genova, L. Crinò, A. Delmonte, D. Turci, D. Signorelli, A. Passaro, H. Soto Parra, A. Catino, L. Landi, F. Gelsomino, M. Tiseo, G. Puppo, F. Roila, S. Ricciardi, G. Tonini, F. Cognetti, L. Toschi, D. Tassinari, A. ScoppolaD. Giannarelli, E. Cortesi

Research output: Contribution to journalArticlepeer-review

Cite this